|
⚲
|
| Raptor Pharmaceuticals Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001203944 |
| Sale | 2009-08-21 ($2.4 M Offered, $2.4 M Sold) |
| Fund | |
| Phone | 4153821390 |
| Address | 9 Commercial Blvd, Suite 200 Novato, 94949 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Raymond Anderson | |
| Todd Zankel | |
| Christopher Starr | |
| Kim Tsuchimoto | |
| Erich Sager |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Minerva Catalyst Strategies, LP
✚
|
0.0 | |
|
Monticello Special Fund II, LLC
✚
|
0.0 | |
|
Mudrick Distressed Senior Secured Fund Offshore, Ltd.
✚
|
0.0 | |
|
NanoEngineering Corp
✚
|
0.0 | |
|
NW1 DC Retail REIT LLC
✚
|
0.0 | |
|
Omega Protein Corp
✚
|
0.0 | |
|
OneNetworks, Inc.
✚
|
0.0 | |
|
Onex Partners V Select LP
✚
|
0.0 | |
|
OnyxPoint Permian Equity Feeder II LLC
✚
|
0.0 | |
|
Accel X Associates L.L.C.
✚
|
0.0 |